摘要 |
The present invention relates to synergistic compositions comprising at least one of allopurinol and oxypurinol and a physiologically acceptable, organic, in vivo sulphydryl group releasing agent and their use in formulations and methods of treatment and prophylaxis of gastrointestinal cancer. |